Chief Scientific Officer
Sus Clinicals Inc.
Disclosure information not submitted.
Utility of Oncopig Liver and Lung Cancer Models for Device-based Therapeutic Studies
Monday, March 25, 2024
12:00 PM – 1:00 PM MT
Preclinical evaluation of yttrium-90 radioembolization in the Oncopig liver cancer model
Monday, March 25, 2024
3:09 PM – 3:18 PM MT